| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 195.96B | 209.72B | 196.77B | 166.88B | 164.02B | 149.08B |
| Gross Profit | 33.52B | 43.82B | 34.23B | 33.40B | 34.91B | 34.77B |
| EBITDA | 17.74B | 26.28B | 18.66B | 17.19B | 19.05B | 21.05B |
| Net Income | 8.10B | 14.03B | 9.02B | 6.60B | 9.78B | 9.28B |
Balance Sheet | ||||||
| Total Assets | 239.46B | 310.41B | 240.18B | 229.58B | 208.34B | 197.73B |
| Cash, Cash Equivalents and Short-Term Investments | 36.57B | 43.46B | 38.06B | 37.41B | 40.00B | 33.22B |
| Total Debt | 31.66B | 64.06B | 24.37B | 22.16B | 22.86B | 22.96B |
| Total Liabilities | 87.80B | 142.79B | 88.20B | 78.85B | 68.92B | 71.36B |
| Stockholders Equity | 141.66B | 157.31B | 141.49B | 140.75B | 132.34B | 120.07B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -25.18B | 2.25B | 2.57B | 8.42B | 552.00M |
| Operating Cash Flow | 0.00 | 7.58B | 17.71B | 8.95B | 15.82B | 8.54B |
| Investing Cash Flow | 0.00 | -32.72B | -12.26B | -6.33B | -5.51B | -7.26B |
| Financing Cash Flow | 0.00 | 31.61B | -6.48B | -5.84B | -4.92B | -4.76B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | ¥602.46B | 8.32 | 5.02% | 2.12% | 9.83% | 130.42% | |
68 Neutral | ¥2.47T | 9.56 | 5.18% | 1.98% | 9.30% | 981.30% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
59 Neutral | ¥173.21B | 13.92 | 6.77% | 2.30% | 6.58% | 63.12% | |
59 Neutral | ¥122.92B | 11.06 | 11.58% | 1.62% | 4.90% | -24.31% | |
58 Neutral | ¥625.27B | 15.50 | 3.12% | 2.83% | -6.02% | 19.06% | |
51 Neutral | ¥13.99B | 7.31 | -111.61% | ― | -0.57% | ― |